Immunoreconstitution after ritonavir therapy in children with human immunodeficiency virus infection involves multiple lymphocyte lineages.
Immunoreconstitution after ritonavir therapy in children with human immunodeficiency virus infection involves multiple lymphocyte lineages.
复制标题
人类免疫缺陷病毒感染儿童利托那韦治疗后的免疫重建涉及多种淋巴细胞谱系。
DOI:
10.1016/s0022-3476(99)70247-7
复制
发表时间:
1999
期刊:
影响因子:
--
通讯作者:
Mueller,BU
中科院分区:
文献类型:
--
作者:
Sleasman,JW;Nelson,RP;Goodenow,MM;Wilfret,D;Hutson,A;Baseler,M;Zuckerman,J;Pizzo,PA;Mueller,BU
ObjectiveTo evaluate lymphocyte reconstitution after protease inhibitor therapy in children with human immunodeficiency virus (HIV) infection.Study designForty-four HIV-infected children receiving ritonavir monotherapy followed by the addition of zidovudine and didanosine were evaluated during a phase I/II clinical trial. The cohort had a median age of 6.8 years and advanced disease (57% Centers for Disease Control and Prevention stage C, 73% immune stage 3) and was naive to protease inhibitor therapy.ResultsAfter 4 weeks of therapy, there was a significant increase in CD4+and CD8+T cells. CD4+T cells continued to increase, whereas CD8+T cells returned to baseline by 24 weeks. Unexpectedly, there was a significant increase in B cells. Changes in CD4+T-cell subsets revealed an initial increase in CD4+CD45RO T cells followed by a sustained increase in CD4+CD45RA T cells. Children <6 years of age had the highest increase in all lymphocyte populations. Significant improvement in CD4+T-cell counts was observed even in those children whose viral burden returned to pre-therapy levels.ConclusionsEarly increases in lymphocytes after ritonavir therapy are a result of recirculation, as shown by increases in B cells and CD4+CD45RO and CD8+T cells. Children exhibited a high potential to reconstitute CD4+CD45RA T cells even with advanced disease and incomplete viral suppression. (J Pediatr 1999;134:597-606)